January 2017

Chairman's Letter
Chairman's Letter
Michael J. Hennessy
From the Editor
From the Editor
Debu Tripathy, MD
The Biology and Therapeutic Approach to BRAF-Mutant Cutaneous Melanoma
Kevin Wood, MD; and Jason Luke, MD, FACP
Breast Cancer
Constructing a Clinicopathologic Prognostic Model for Triple-Negative Breast Cancer
Kimberly Thomas, MD, MSc; Jean Shiao, BS; Roshni Rao, MD; Abu Minhajuddin, PhD; Ann Spangler, MD, MACM; Marilyn Leitch, MD; Rachel Wooldridge, MD; Aeisha Rivers MD; Barbara Haley; MD, DW; Nathan Kim, MD, PhD; and Asal Rahimi, MD, MS
Window of Opportunity Studies
The Window Is Wide Open: Evaluating the Rationale for Window of Opportunity Studies in Breast Cancer with a Focus on Immune Therapies
Nancy A. Nixon, MD, and Sunil Verma, MD
Renal Cell Carcinoma
Multiple Primary Urogenital Malignancies: A Case of Synchronous Renal Cell Carcinoma and Penile Squamous Cell Carcinoma
Stephani C. Wang, MD, Rebecca L. O’Malley, MD, Lezah McCarthy, MD, and Syed Mehdi, MD
CDK4/6 Inhibitors in Breast Cancer
Richard S. Finn, MD